Vanguard Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
Vanguard Capital Management's CDNA Position: Q3 2026 in Review
Vanguard Capital Management reduced its CareDx (CDNA) stake by 0.18% in Q3 2026, selling an estimated $178K and leaving 2,193,550 shares worth $143M. The position accounts for ﹤0.01% of the portfolio, ranked #1309.
Vanguard Capital Management first reported a position in CDNA in Q1 2026 and has held it in 3 quarters since. 308 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.
- Vanguard Capital Management held 2,193,550 shares of CareDx worth $143M as of Q3 2026.
- Vanguard Capital Management sold 3,925 CareDx shares in Q3 2026, an estimated $178K.
- CareDx made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1309 holding.
- Vanguard Capital Management first reported a position in CareDx in Q1 2026 and has held it in 3 quarters since.
- 308 funds tracked by Wall St. Rank held CareDx as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.